An immunosuppressive ectoenzyme-expressing T cell population is associated with non-responsiveness to immune checkpoint blockade in metastatic melanoma patients

被引:0
|
作者
Mitra, Ankita
Thompson, Brian
Woods, David M.
Weber, Jeffrey S.
机构
关键词
D O I
10.1158/1538-7445.AM2023-2283
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2283
引用
收藏
页数:2
相关论文
共 50 条
  • [1] A POPULATION OF ECTOENZYME EXPRESSING T-CELLS WITH AN IMMUNOSUPPRESSIVE PHENOTYPE ARE ASSOCIATED WITH CHECKPOINT IMMUNOTHERAPY RESISTANCE IN METASTATIC MELANOMA PATIENTS
    Woods, David
    Amato, Carol
    Strange, Ann
    Thompson, Brian
    Weber, Jeffrey
    Mitra, Ankita
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1082 - A1082
  • [2] T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma
    Alexander X. Lozano
    Aadel A. Chaudhuri
    Aishwarya Nene
    Antonietta Bacchiocchi
    Noah Earland
    Matthew D. Vesely
    Abul Usmani
    Brandon E. Turner
    Chloé B. Steen
    Bogdan A. Luca
    Ti Badri
    Gunsagar S. Gulati
    Milad R. Vahid
    Farnaz Khameneh
    Peter K. Harris
    David Y. Chen
    Kavita Dhodapkar
    Mario Sznol
    Ruth Halaban
    Aaron M. Newman
    Nature Medicine, 2022, 28 : 353 - 362
  • [3] T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma
    Lozano, Alexander X.
    Chaudhuri, Aadel A.
    Nene, Aishwarya
    Bacchiocchi, Antonietta
    Earland, Noah
    Vesely, Matthew D.
    Usmani, Abul
    Turner, Brandon E.
    Steen, Chloe B.
    Luca, Bogdan A.
    Badri, Ti
    Gulati, Gunsagar S.
    Vahid, Milad R.
    Khameneh, Farnaz
    Harris, Peter K.
    Chen, David Y.
    Dhodapkar, Kavita
    Sznol, Mario
    Halaban, Ruth
    Newman, Aaron M.
    NATURE MEDICINE, 2022, 28 (02) : 353 - +
  • [4] Immune Checkpoint Blockade in Patients With Melanoma Metastatic to the Brain
    Di Giacomo, Anna Maria
    Margolin, Kim
    SEMINARS IN ONCOLOGY, 2015, 42 (03) : 459 - 465
  • [5] Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma
    Fairfax, Benjamin P.
    Taylor, Chelsea A.
    Watson, Robert A.
    Nassiri, Isar
    Danielli, Sara
    Fang, Hai
    Mahe, Elise A.
    Cooper, Rosalin
    Woodcock, Victoria
    Traill, Zoe
    Al-Mossawi, M. Hussein
    Knight, Julian C.
    Klenerman, Paul
    Payne, Miranda
    Middleton, Mark R.
    NATURE MEDICINE, 2020, 26 (02) : 193 - +
  • [6] Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma
    Benjamin P. Fairfax
    Chelsea A. Taylor
    Robert A. Watson
    Isar Nassiri
    Sara Danielli
    Hai Fang
    Elise A. Mahé
    Rosalin Cooper
    Victoria Woodcock
    Zoe Traill
    M. Hussein Al-Mossawi
    Julian C. Knight
    Paul Klenerman
    Miranda Payne
    Mark R. Middleton
    Nature Medicine, 2020, 26 : 193 - 199
  • [7] Immune profiling for improving responsiveness to ipilimumab plus nivolumab checkpoint blockade treatment in patients with metastatic melanoma
    Baginska, Joanna
    Chen, Jiajia
    Tarantino, Giuseppe
    Giobbie-Hurder, Anita
    Weirather, Jason L.
    Severgnini, Mariano
    Manos, Michael
    Burke, Kelly
    Russell, Janice D.
    Brainard, Martha
    Gabriel, Elizabeth
    Brennick, Ryan
    Nazzaro, Matthew
    Hathaway, Emma
    Holovatska, Marta
    Manuszak, Claire
    Ranashinge, Srinika
    Liu, David
    Hodi, F. Stephen
    CANCER RESEARCH, 2024, 84 (06)
  • [8] Humanized mouse model: A model to understand mechanisms of immune non-responsiveness to immune checkpoint inhibitors in melanoma.
    Somasundaram, Rajasekharan
    Samarkina, Anastasia
    Connelly, Thomas
    Choi, Robin
    Choi, Hedy
    Muthumani, Kar
    Xu, Xiaowei
    Kaestner, Klaus
    Herlyn, Meenhard
    CANCER RESEARCH, 2020, 80 (19) : 43 - 43
  • [9] T cell immune landscape in melanoma patients before and post immune checkpoint blockade treatment
    Luo, Ying
    Yao, Chen
    Wu, Tuoqi
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
  • [10] T cell immune landscape in melanoma patients before and post immune checkpoint blockade treatment
    Luo, Ying
    Yao, Chen
    Wu, Tuoqi
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (10)